A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Clinical trial NCT07058012 · RECRUITING
Trial details
- NCT number
- NCT07058012
- Sponsor
- NSABP Foundation Inc
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-17
- Primary completion
- 2029-04-17
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.